This is the first seminar in our educational series on cancer immunotherapies featuring: Novel treatment strategies and their clinical implementation in melanoma and beyond.
Download PROGRAM here and please REGISTER below. If you for some reason may not attend, please let us know 24 hours prior to the event.
Target group: Clinicians. We will limit the number of company representatives to 1. Others may watch the live streaming of this event.
The immuno-oncology educational series is kindly supported by Oslo Cancer Cluster member companies MSD and BMS.
Moderator: Dr. Oddbjørn Straume, Associate Professor, Dept. of Clinical Science, Haukeland University Hospital, Bergen
14:30–15:00 Registration and coffee
15:00–15:10 Welcome and introduction, Dr. Oddbjørn Straume, Haukeland University Hospital, Bergen
15:10–15:50 International key note speaker: Prof. Dr. Erika Richtig, Dept. of Dermatology and Venerology, Medical University of Graz, Austria
Cancer Immunotherapy in Melanoma – novel treatment strategies and their clinical implementation,
16:10–16:3 Else Marit Inderberg Suso, Dept. of Cellular Therapy, Oslo University Hospital
Biomarkers and Immunological monitoring of patients – status and challenges
16:35–16:55 Dr. Odd Terje Brustugun, Dept. of Oncology, OUS
Cancer Immunotherapy in lung cancer – where are we today?
16:55 – 17:00 Wrap-up and Closing
17:00–18:00 Networking session with light refreshments
We look forward to a stimulating seminar